'High hopes for treatment': Australian stakeholder perspectives of the clinical translation of advanced neurotherapeutics for rare neurological diseases.

Authors
Category Primary study
JournalHEALTH EXPECTATIONS
Year 2024
This article has no abstract
Epistemonikos ID: 0e87307c0c963b1a085ef2db5093aac71a4a9080
First added on: Feb 25, 2025